Linezolid contraindications: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Linezolid }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | publisher = | date = | accessdate = }}</ref> | ===Hypersensitivity=== | ||
ZYVOX formulations are contraindicated for use in patients who have known hypersensitivity to linezolid or any of the other product components. | |||
===Monoamine Oxidase Inhibitors=== | |||
Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g., [[phenelzine]], [[isocarboxazid]]) or within two weeks of taking any such medicinal product.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 04:12, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Hypersensitivity
ZYVOX formulations are contraindicated for use in patients who have known hypersensitivity to linezolid or any of the other product components.
Monoamine Oxidase Inhibitors
Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g., phenelzine, isocarboxazid) or within two weeks of taking any such medicinal product.[1]
References
Adapted from the FDA Package Insert.